Researchers at the National University of Singapore (NUS) have demonstrated that intermittent, low-intensity magnetic pulses can transform tumor-associated macrophages (TAMs)—corrupted immune cells that typically promote cancer growth—into active fighters that attack and destroy breast cancer cells. According to a study published on June 4, 2026, in the journal Smart Medicine, the pulsed electromagnetic fields (PEMFs) completely eradicated tumors in 75 percent of tested preclinical models after just four 30-minute sessions, entirely without chemotherapy.
NUS Researchers Use Magnetic Pulses to Reprogram Breast Cancer Immune Cells
How Pulsed Electromagnetic Fields Target Cancer Cells
Pulsed electromagnetic fields operate by applying gentle, low-energy magnetic waves that pass through the human body without generating heat or damaging surrounding tissue. According to Alfredo Franco-Obregon, principal investigator at the NUS Institute for Health Innovation and Technology who led the research, the pulses act as a biological tuning fork when interacting with cells.
When the magnetic waves pass through cells, they engage specialized microscopic gates on the cell surface called TRPC1 channels, which function as biological antennae. Opening these gates initiates a controlled wave of calcium into the cell, stimulating the mitochondria. In healthy tissues, this process resembles a mild workout that boosts cellular repair. However, in cancer cells, the excess stimulation overloads an unstable system.
Franco-Obregon explained to The Straits Times that breast cancer cells overexpress the calcium channel protein to fuel rapid proliferation and spreading. By targeting this vulnerability with PEMFs, the research team achieved a two-pronged precision approach:
- Metabolic Stress: The magnetic pulses induce acute calcium and metabolic stress inside cancer cells without harming healthy tissue, which simultaneously enhances the uptake of standard chemotherapeutic drugs like doxorubicin.
- Immune Reprogramming: The therapy reprograms TAMs from an anti-inflammatory state that protects tumors into a pro-inflammatory state that consumes breast cancer cells.
Reprogramming Macrophages from Medics to Soldiers
Solid tumors frequently recruit and corrupt nearby immune cells to accelerate growth and metastasis. Among these recruited cells are macrophages, which generally divide into two primary categories. M1 macrophages act as pro-inflammatory soldiers eliminating bacteria and viruses, while M2 macrophages function as anti-inflammatory medics orchestrating tissue repair.
Cancer cells routinely corrupt most TAMs into adopting the M2 state, which suppresses immune attacks. According to findings published in Smart Medicine, a brief 10-minute exposure to PEMFs activates TRPC1 channels on M2-like TAMs, setting off a signaling cascade that converts them into aggressive M1-like cancer-killing soldiers. This signature simultaneously disrupts the communication loop between the cancer and the macrophages.
Addressing Global Breast Cancer Burdens and Treatment Challenges
Global breast cancer cases are projected to rise by a third, climbing from 2.3 million in 2023 to more than 3.5 million by 2050, according to data cited by NUS researchers. Annual deaths during that same period may nearly double from 764,000 to nearly 1.4 million. In Singapore, breast cancer is the most common cancer among women, accounting for roughly 30 percent of all female cancer diagnoses. Data from the Singapore Cancer Registry Annual Report of 2023 indicates that one in 12 women will develop the disease in their lifetime.
Standard breast cancer treatments frequently encounter hurdles such as drug resistance, treatment-related toxicities, and tumor heterogeneity, where cancer cells display distinct genetic and physical differences. Building upon prior work showing that brief PEMF exposure enhances doxorubicin uptake by breast cancer cells, the NUS team aims to maximize treatment efficacy while slashing toxicity to preserve patient quality of life.
Related reading